A unique facility in Melbourne containing hundreds of childhood cancer tissue samples has produced a first-of-its-kind ...

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

Garo Armen serves as chairman and CEO of Agenus Inc., a clinical-stage biotechnology company based in Lexington, ...

Kaposi Sarcoma is the most common HIV-related cancer in Uganda and, historically, one of the leading cancers treated at the Uganda Cancer Institute ...

A common childhood virus, BK virus, dormant in the urinary tract, is now linked to DNA damage increasing bladder cancer risk.

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

To understand more about the detox habits that can help reduce cancer risks, HT Lifestyle reached out to Dr Siddharth Turkar, consultant medical oncologist at Apollo Hospitals, Navi Mumbai. He ...

Dr. Reddy’s receives exclusive rights to develop and commercialise Eftilagimod Alfa in all countries outside North America, ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE(-) level) by independent review committee - ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

If a doctor tells you have a tumour, what does that actually mean? Do you have cancer? Let’s clear up any confusion.